Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Circulatory system drugs >  Antihypertensive drugs >  Enalaprilat

Enalaprilat

Basic information Safety Supplier Related

Enalaprilat Basic information

Product Name:
Enalaprilat
Synonyms:
  • ENALAPRILAT HYDRATE
  • ENALAPRILAT USP(CRM STANDARD)
  • Enalaprilat (Enalapril EP Impurity C)
  • Enalapril maleate impurity C
  • Enalapril acid
  • L-Proline, 1-[N-(1-carboxy-3-phenylpropyl)-L-alanyl]-, (S)-
  • N-[1(S)-Carboxy-3-phenylpropyl]-L-alanyl-L-proline
  • 1-[N-[(S)-1-Carboxy-3-phenylpropyl]-L-alanyl]-L-proline
CAS:
76420-72-9
MF:
C18H24N2O5
MW:
348.39
EINECS:
278-459-3
Product Categories:
  • Metabolite
  • Intermediates & Fine Chemicals
  • Active Pharmaceutical Ingredients
  • Various Metabolites and Impurities
  • Metabolites & Impurities
  • Pharmaceuticals
Mol File:
76420-72-9.mol
More
Less

Enalaprilat Chemical Properties

Melting point:
148-151°C
alpha 
D -67.0° (0.1M HCl)
Boiling point:
601.0±55.0 °C(Predicted)
Density 
1.286±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
Very slightly soluble or slightly soluble in water, sparingly soluble in methanol, practically insoluble in acetonitrile.
pka
pKa 2.30 (Uncertain);3.39 (Uncertain)
Water Solubility 
Soluble in water with heating (~60°C)
CAS DataBase Reference
76420-72-9(CAS DataBase Reference)
EPA Substance Registry System
L-Proline, N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl- (76420-72-9)
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22
WGK Germany 
2
More
Less

Enalaprilat Usage And Synthesis

Description

Enalaprilat is the diacid active metabolite of enalapril. As an injectable ACE inhibitor, it is reportedly useful in the treatment of uncomplicated accelerated hypertension and hypertensive emergencies. Enalaprilat is more effective in reducing blood pressure in the elderly than in the young, despite the fact that renin activity is lower in old age.

Chemical Properties

White Crystalline Solid

Originator

Merck (USA)

Uses

Enalapril is a ACE (angiotensin-converting enzyme) inhibitor, suggested to be more potent than Captopril (sc-200566). Studies indicate that Enalapril downregulates the expression of IL-β, IL-6, and NF-κB. Further studies show that Enalapril upregulates the expression of VEGF and heme oxygenase-1. Enalaprilat reports demonstrate that the compound has some antioxidant activity, which does not include the PKC-NADPH oxidase pathway.

Uses

Active metabolite of Enalapril. A nonsulfhydryl dipeptide angiotensin converting enzyme (ACE) inhibitor

Uses

primary hypertension

Definition

ChEBI: Enalapril in which the ethyl ester group has been hydrolysed to the corresponding carboxylic acid. Enalaprilat is an angiotensin-converting enzyme (ACE) inhibitor and is used (often in the form of its prodrug, enalapril) in the treatment of hypertension an heart failure, for reduction of proteinuria and renal disease in patients with nephropathies, and for the prevention of stroke, myocardial infarction, and cardiac death in high-risk patients. Unlike enalapril, enalaprilat is not absorbed by mouth but is g ven by intravenous injection, usually as the dihydrate.

brand name

Vasotec (Biovail);Renitec.

EnalaprilatSupplier

3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Email
chenyj@titansci.com
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Wuhan Haizheng Industry & Trade Development Co. Ltd
Tel
027-8866 0053/88660577/88660578
S.Z. PhyStandard Bio-Tech. Co., Ltd.
Tel
0755-83725681-603